A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to BRAF V600E-mutant Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3